Division Of Clinical Pharmacology

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease. Read More

A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation. Read More

Variation in the gene for the beta-1 adrenergic receptor increases the risk that a patient will have an abnormal heart rhythm after cardiac surgery. Read More

Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling. Read More

Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks. Read More

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week. Read More

The 50th anniversary of the Division of Clinical Pharmacology will be celebrated Thursday, June 6, with a daylong scientific symposium and luncheon in the Student Life Center. Read More